{
  "scenario_id": "natural-science-nature",
  "scenario_name": "Natural Science Journal Article",
  "domain": "natural_science",
  "venue": "Nature",
  "methodology_type": "experimental",
  "description": "Test scenario for experimental biology research in flagship journal",

  "context": {
    "ThesisContext": {
      "project_id": "test-nat-001",
      "title": "CRISPR-Cas9 Mediated Correction of Sickle Cell Disease in Human Hematopoietic Stem Cells",
      "research_questions": [
        "Can precise CRISPR-Cas9 editing correct the HBB E6V mutation in patient-derived HSCs with clinically relevant efficiency?",
        "What is the optimal delivery method to maximize on-target editing while minimizing off-target effects?",
        "Do corrected HSCs maintain long-term engraftment and produce functional adult hemoglobin in vivo?"
      ],
      "contributions": [
        "Novel high-fidelity Cas9 variant with 95% reduction in off-target activity",
        "Optimized electroporation protocol achieving 80% editing efficiency in primary HSCs",
        "Long-term (18-month) engraftment data in immunodeficient mouse model",
        "First-in-human safety data from Phase I clinical trial (n=6)"
      ],
      "terminology_glossary": [
        {
          "term": "hematopoietic stem cells",
          "definition": "Multipotent stem cells that give rise to all blood cell types",
          "abbreviation": "HSCs"
        },
        {
          "term": "CRISPR-Cas9",
          "definition": "A genome editing technology using a guide RNA to direct Cas9 nuclease to specific DNA sequences",
          "abbreviation": null
        },
        {
          "term": "HBB gene",
          "definition": "The gene encoding the beta subunit of hemoglobin",
          "abbreviation": null
        },
        {
          "term": "E6V mutation",
          "definition": "The specific point mutation (glutamic acid to valine at position 6) causing sickle cell disease",
          "abbreviation": null
        },
        {
          "term": "off-target effects",
          "definition": "Unintended genetic modifications at genomic sites similar to the target sequence",
          "abbreviation": null
        },
        {
          "term": "engraftment",
          "definition": "The process by which transplanted stem cells establish and regenerate in the recipient",
          "abbreviation": null
        }
      ],
      "style_guide": {
        "citation_style": "Nature",
        "tense_rules": {
          "methods": "past",
          "results": "past",
          "discussion": "present"
        },
        "formatting": {
          "heading_style": "minimal (Main Text, Methods, References)",
          "figure_prefix": "Fig.",
          "table_prefix": "Table",
          "extended_data": "Extended Data Fig., Extended Data Table"
        },
        "methodology_type": "experimental",
        "evidence_standards": {
          "statistical_significance": "required",
          "biological_replicates": "minimum n=3",
          "technical_replicates": "as appropriate",
          "blinding": "required for clinical data"
        }
      },
      "chapter_summaries": [],
      "bibliography_keys": [
        "jinek2012programmable",
        "doudna2014genome",
        "frangoul2021crispr",
        "esrick2021post",
        "rees2018base"
      ],
      "word_budget": {
        "total": 3000,
        "abstract": 150,
        "main_text": 2500,
        "online_methods": "separate",
        "figure_legends": 350
      }
    }
  },

  "validation_criteria": {
    "must_include": [
      "all research_questions addressed with data",
      "sample sizes for all experiments",
      "statistical methods specification",
      "ethics approval statement"
    ],
    "must_not_include": [
      "claims beyond data support",
      "speculation without hedging",
      "clinical claims without Phase I data qualifier"
    ],
    "expected_structure": "Nature format (concise main text, detailed methods)",
    "tone": "precise, cautious about implications, data-driven",
    "word_count_tolerance": 0.05
  },

  "test_expectations": {
    "introduction_writer": {
      "should_reference": ["CRISPR-Cas9", "hematopoietic stem cells", "sickle cell disease"],
      "should_not_assume": ["clinical application certainty", "universal applicability"],
      "structure": ["disease burden and unmet need", "current approaches and limitations", "this study's approach", "key findings preview"]
    },
    "methodology_writer": {
      "should_reference": ["off-target effects", "engraftment", "electroporation"],
      "sections": ["guide RNA design", "cell isolation and culture", "editing protocol", "analysis methods", "in vivo studies", "clinical protocol"],
      "detail_level": "sufficient for replication"
    }
  }
}
